scholarly journals PMH91 EXAMINATION OF DOCTORS' PRACTICE AND PRESCRIBING PATTERNS TOWARD SELECTIVE SEROTONIN REUPTAKE INHIBITORS AND SERTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS

2010 ◽  
Vol 13 (3) ◽  
pp. A121-A122
Author(s):  
O Baser ◽  
L Wang ◽  
C Gust ◽  
A Dysinger
2005 ◽  
Vol 45 (2) ◽  
pp. 115-120 ◽  
Author(s):  
Ajit Shah ◽  
Lubbaba Lodhi

Suicide rates in the elderly have declined in many countries in recent years. This decline has been reported to be associated with increased prescribing of antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs), antipsychotics and antimanic drugs and reduced prescribing of barbiturates, hypnotics and sedatives. This study examined the relationship between prescribing patterns of individual psychotropic drugs and suicide rates by specific methods of elderly suicides. There was a negative correlation between the prescription of tricyclic antidepressants, selective serotonin reuptake inhibitors, antipsychotics, antimanic drugs and non-opiate analgesics and a decline in elderly suicide rates due to poisoning by solid and liquid substances, hanging, strangulation and suffocation, drowning, firearms and explosives, and jumping from high places. There was a positive correlation between the prescription of barbiturates, hypnotics and sedatives and elderly suicide rates due to poisoning by solid and liquid substances, hanging, strangulation and suffocation, drowning, firearms and explosives, and jumping from high places. This study demonstrated that changes in prescribing patterns of individual psychotropic drugs do influence elderly suicide rates of the commonly used methods of suicide and suggest that this may be due to more accurate diagnostic-specific prescribing of psychotropic drugs.


2018 ◽  
Author(s):  
Shadi Doroudgar ◽  
Baovy Dang

Antidepressant medications have numerous clinical uses in the field of psychiatry. There are many antidepressant classes, with the selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors being commonly used in clinical practice for depression and anxiety. Although these medications are effective, complete clinical effect is not rapid and full relief of symptoms can take more than a month. However, side effects with antidepressants can be expected to occur upon initiation of treatment and may lead to patient nonadherence. Education and appropriate patient counseling are necessary to assure that the therapeutic effects of medications are maximized. Treatment with antidepressants should be tailored to patient-specific criteria. This review contains 1 figure, 4 tables and 43 references Key Words: antidepressants, FDA-approved, obsessive-compulsive disorder, monoamine oxidase, MAOIs, selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, tricyclic antidepressants.


Medicina ◽  
2007 ◽  
Vol 43 (5) ◽  
pp. 412
Author(s):  
Mantas Jakimavičius ◽  
Audrius Sveikata ◽  
Paulius Vainauskas ◽  
Rimas Jankūnas ◽  
Loreta Mikučionytė ◽  
...  

Depression is one of the leading causes of disability worldwide, affecting 121 million people in whole world. In many developed countries, the number of prescriptions for antidepressants increased steeply during the 1990s. The objective of the present study was to evaluate the antidepressant prescribing patterns in all regions of Lithuania during 2003–2004, to analyze the use within different antidepressant groups, and to examine trends in age- and gender-specific antidepressant use. Antidepressants were classified into three groups according to Anatomic Therapeutic Chemical (ATC) Classification specifying the defined daily doses. The results of our study show an increase in the use of reimbursed antidepressants except tricyclic in 2004 when compared to 2003. Increase in the use of selective serotonin reuptake inhibitors and other nontricyclic antidepressants is probably related to their better tolerability, improved risk-benefit ratio, and less toxicity in overdose. There was no increase in the percentage of consumed selective serotonin reuptake inhibitors in elderly patients when compared with younger ones, despite elderly patients are most likely to benefit from reduced sedation, less antimuscarinic and less cardiac toxicity of selective serotonin reuptake inhibitors. The prevalence of the antidepressant use is the highest among middle-aged people (40–59 years), while the young (under 20) and elderly (older than 70) patients receive mostly selective serotonin reuptake inhibitors. Additional studies should be carried out in order to assess drug-prescribing patterns in accordance with the guidelines of depression treatment in Lithuania considering diagnosis, dosage, and duration of treatment.


Sign in / Sign up

Export Citation Format

Share Document